Chemed was Schwartz's 11th-largest holding at the end of June. By the end of September, it had been demoted to 17th place out ...

By contrast, EEM is focused exclusively on emerging markets, with 1,198 holdings and heavier exposure to technology (25%) and ...

When it comes to putting cash into stocks that you can buy and hold for the long run, and could outperform for years as part ...

Revenue of $1.88 billion in the second quarter was up 18.5% year over year, and net income nearly tripled from one year ago to $439.2 million. Viking Holdings reported occupancy of 95.6%, and an 8.8% ...

MercadoLibre is the leader in e-commerce and fintech services in a region of 650 million people. It has gained more than 76 ...

Medicare Advantage is an alternative to original Medicare that typically includes drug coverage. Medicare Advantage plans commonly offer extra benefits beyond what original Medicare gives enrollees.

If you're a retiree who's been struggling financially, you can't expect 2026's Social Security COLA to do you do all that much good. A better idea is to take a look at your financial situation and see ...

Palantir's performance over the last few years has been commendable, but the stock price is simply too frothy at this point, ...

One big perk of Medicare Advantage is that these plans tend to offer supplemental benefits beyond what original Medicare ...

According to Fidelity, a 65-year-old person retiring in 2025 can expect to spend $172,500, on average, on medical and healthcare expenses throughout their retirement -- and that doesn't even include ...

The spoils of outperformance go to the investor who puts in the work and finds opportunities to be right where others are ...

Data#3 shares have brought investors strong returns in 2025. How much further upside is there, according to Macquarie?